Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Coronavirus Update: FDA Tries To Control J&J’s Vaccine, Extended Use Of Paxlovid

May 06 2022

• By Scrip Team

Related Content

Coronavirus Update: J&J Shows Promise Against Omicron, UK Nod For Paxlovid

Jan 04 2022

Eiger Has Positive Data For Its COVID-19 Drug, But Faces Uncertain Market

Mar 17 2022

Can Adagio’s Adintrevimab Hold Up Against Omicron BA.2?

Mar 30 2022

J&J Continues Signaling Aggressive M&A Approach To Drive Growth

Apr 19 2022

Pfizer On Paxlovid: "There's Still A Long Way To Go"

May 03 2022

Pfizer Highlights Next I&I Star As Xeljanz Sales Fall

May 04 2022

Coronavirus Update: As Pfizer/BioNTech Begin Omicron Vaccine Tests, Regulators Want To Explore Multivalent Route

Jan 26 2022

Gilead Sees HIV Business Return To Sales Growth As Oncology Gets Boost

Apr 28 2022

Related Companies

Pfizer Inc.

Johnson & Johnson

BioNTech SE

Moderna, Inc.

Regeneron Pharmaceuticals, Inc.

Merck & Co., Inc.

Ridgeback Biotherapeutics LP

Gilead Sciences, Inc.

Vir Biotechnology, Inc.

GSK plc

Invivyd, Inc.

Eiger BioPharmaceuticals, Inc.

Additional Topics

FDA Coronavirus COVID-19 Vaccines Regulation BioPharmaceutical

More from COVID-19

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.